Zusammenfassung
Im allgemeinen bedürfen Infektionserkrankungen einer antibiotischen Therapie. Es gibt jedoch keine Universalantibiotika, die jeden Krankheitserreger in therapeutisch erreichbaren Konzentrationen erfassen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Food and drug administration (1972) Rules and regulations: antibiotic susceptibility discs. Federal Register 37: 20525
Methoden zur Empfindlichkeitsprüfung anaerober bakterieller Krankheitserreger gegen Chemotherapeutika (1984) DIN-Norm 58944, Teil 1–2. Beuth, Berlin
Methoden zur Empfindlichkeitsprüfung von bakteriellen Krankheitserregern (auβer Mykobakterien) gegen Chemotherapeutika (1981) DIN-Norm 58940, Teil 1–6. Beuth, Berlin
Approved Standard ASM-2. Performance standards for antimicrobial disc susceptibility tests (1979) 2nd ed. National Committee for Clinical Laboratory Standards, Villanova
Dilution procedures for susceptibility testing of aerobic bacteria. Approved standard M7-A (1985) National Committee for Clinical Laboratory Standards, Villanova
Editorial (1979) Vergleich von verschiedenen normierten Methoden für die Empfindlichkeitsprüfung von Bakterien. Forum Mikrobiol 2: 129–132
Working Party of the British Society for Antimicrobial Chemotherapy (1988) Breakpoints in in-vitro antibiotic sensitivity testing. J Antimicrob Chemother 21: 701–710
Anhalt JP, Washington JA (1984) Antimicrobial susceptibility test of aerobic and facultativ anaerobic bacteria. In: Washington JA (ed) Laboratory Procedures in Clinical Microbiology ( 2nd ed ). Springer, New York Heidelberg Berlin
Ansorg R, Bagger F (1977) Untersuchungen zur Empfindlichkeitsbestimmung von Candida albicans gegen 5-Fluorocytosin. Arztl Labor 23: 458–464
Barry AL, Badal RE (1982) Quality control limits for the agar overlay disc diffusion antimicrobial susceptibility test. J Clin Microbiol 16: 1145–1147
Barry AL, Thornsberry C (1985) Susceptibility testing: diffusion test procedures. In: Lennette EH, Balows A, Hausler WJ, Shadomy HJ (eds) Manual of Clinical Microbiology, 4th ed. American Society for Microbiology, Washington
Bähr V, Ulimann U (1983) Biochemische Charakterisierung von β-Laktamasen. In: Betalaktamasen. Fischer, Stuttgart New York
Bockhorst W, Schiek W (1983) Ablösung des Agardiffusionstestes für die routinemäβige Sensibilitätsprüfung von Bakterien gegen Antibiotika durch Bestimmung der MHK im Mikrotiter-Verfahren. Laboratoriumsmedizin 7: 60–65
Borgers H, de Brabander M, van den Bossche H, van Cutsem J (1979) Promotion of Pseudomycelium formation of Candida albicans in culture. Postgrad Med J 55: 687–691
Borgers M, de Brabander M, van den Bossche H, van Cutsem J (1979) The effects of the new antifungal ketoconazole on Candida albicans. 7th Congress of the International Society for Human and Animal Mycology ( IS-HAM ), Jerusalem/Israel
Boyce JM (1984) Revaluation of the ability of the standardized disc diffusion test for detect methicillin-resistant strains of Staphylococcus aureus. J Clin Microbiol 19:813– 817
Braveny I, Machka K, Bartmann K, Fabricius K, Daschner J, Petersen KF, Grimm H, Ullmann U, Freiesleben H (1980) Antibiotikaresistenz von Haemophilus influenzae in der Bundesrepublik Deutschland. Dtsch Med Wochenschr 105: 1341–1344
Braveny I (1979) In-vitro-Aktivität von Cefaclor gegen Haemophilus influenzae im Vergleich zu verschiedenen oralen Chemotherapeutika. Infection 7: 532–535
Bridson EY (1978) Die Zusammensetzung unvollständig definierter Kulturmedien zur Überwindung des antibiotischen Antagonismus. Immun Infekt 6: 229–232
Bryan LE (1988) General mechanisms of resistance to antibiotics. J Antimicrob Chemother 22: 1–15
Bryan LE, O’Hara K, Wong S (1984) Lipopolysaccharide changes in impermeability- type aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 26: 181–186
Calhoun DL, Galgiani JN (1984) Analysis of pH and buffer effects on flucytosine activity in broth dilution susceptibility testing of Candida albicans in two synthetic media. Antimicrob Agents Chemother 26: 364–367
Casals JB, Pederson OG (1978) Antimicrobial sensitivity testing using neo-sensitabs. Technical Manual. A/S Rosco Taastrap, Dänemark
Charles D, Obst D (1954) Placental transmission of antibiotics. J Obstet Gynecol Br Emp 61: 750–757
Dermoumi H (1979) Resistenzbestimmung bei klinisch bedeutsamen Sproβpilzen — ein Vergleich zwischen Reihenverdünnungs- und Hemmhoftest. Mykosen 23: 1–9
Dickert H, Machka K, Braveny I (1981) The uses and limitations of disc diffusion in the antibiotic sensitivity testing of bacteria. Infection 9: 18–24
Dillin LK, How SE (1984) Early detection of oxacillin-resistant staphylococcal strains with hypertonic broth diluent for microdilution panels. J Clin Microbiol 19: 473–476
Doern GV, Jones RN (1988) Antimicrobial susceptibility testing of Haemophilus influenzae, Branhamella catarrhalis and Neisseria gonorrhoeae. Antimicrob Agents Chemother 32: 1747–1753
Doern GV, Jorgensen JH, Thornsberry C, Preston DA, Tubert T, Redding JS, Maher LA (1988) National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae. Antimicrob Agents Chemother 32: 180–185
Doern GV, Tubert T (1987) Detection of β-lactamase activity among clinical isolates of Branhamella catarrhalis with six different β-lactamase assays. J Clin Microbiol 25: 1380–1383
Doern GV, Tubert T (1987) Disk diffusion susceptibility testing of Branhamella catarrhalis with ampicillin and seven other antimicrobial agents. Antimicrob Agents Chemother 31: 1519–1523
Doern GV, Tubert T (1987) Effect of inoculum size on results of macrotube broth dilution susceptibility tests with Branhamella catarrhalis. J Clin Microbiol 25: 1576–1578
Drouhet E, Barale T, Bastide J, Jouvet S, Maillie M, Biava M, Kures L, Percebois G, Blanc C, Borderon JC, Camerlynck P, Cazaux M, Seguela J, Dupont B, Koening H, Kremer M, Billiault X, Goullier A, Grillot R, Ambroise-Thomas P, Regli P, Viviani MA, Tortorano AM (1981) Standardisation de l’antibiogramme antifongique rapport du groupe d’études de la Société Française de Mycologie Médicale. Bull Soc Franç Med Mycol 10: 131–134
Ericsson HM, Sherris JC (1971) Antibiotic sensitivity testing: report of an international collaborative study. Acta Pathol Microbiol Immunol Scand [B] 217: 1
Gavan TL, Barry AL (1980) Microdilution test procedures. In: Lennette EH, Balows A, Hausler WJ, Truant JP (eds) Manual of Clinical Microbiology 3rd ed. American Society for Microbiology, Washington
Godfrey AJ, Hatlelid L, Bryan LE (1984) Correlation between lipopolysaccharide structure and permeability resistance in /Mactam-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 26: 181–186
Greenwood D (1981) In vitro Veritas? Antimicrobial susceptibility tests and their clinical relevance. J Infect Dis 144: 380–385
Greenwood D (1978) Inokulum-Effekte und bakterielle Resistenz. Immun Infekt 6: 226–228
Hoeprich PD, Finn PD (1972) Obfuscation of the activity of antifungal antimicrobics by culture media. J Infect Dis 126: 353–361
Isenberg HD, d’Amato RR (1984) Rapid methods for antimicrobic susceptibility testing. In: Ristuccia AM, Cunha BA (eds) Antimicrobial Therapy. Raven Press, New York
Jenkins RD, Stevens SL, Craxthorn JM, Thomas TW, Guinan ME, Matsen JM (1985) False susceptibility of enterococci to aminoglycosides with blood-enriched Mueller-Hinton-Agar for disc susceptibility testing. J Clin Microbiol 22: 369–374
Jones RN, Edson DC (1985) Antibiotic susceptibility testing accuracy. Arch Pathol Labor Med 109: 595–601
Kavanagh F (1963) Analytic Microbiology. Academic Press, New York
Kinsman OS, Naidoo J, Noble WC (1985) Some effects of plasmids coding for antibiotic resistance on the virulence of Staphylococcus aureus. Br J Exp Pathol 66: 325–332
Klein P (1957) Bakteriologische Grundlagen der chemotherapeutischen Laboratoriumspraxis. Springer, Berl in Heidelberg
Klugman KP, Koornhof HJ (1988) Disk susceptibility testing of penicillin-resistant pneumococci. J Clin Microbiol 26: 610–611
Knothe H, Dette GA (1985) Antibiotics in pregnancy: toxicity and teratogenicity. Infection 13: 49–51
Knothe H (1981) Aktuelle Chemotherapie: Antibiotika gegen Enterobacter. Umweltmedizin 4: 16
Knothe H (1982) Aktuelle Chemotherapie: Pneumokokken-wirksame Antibiotika. Umweltmedizin 5: 21
Knothe H (1982) Aktuelle Chemotherapie: Staphylokokken-wirksame Antibiotika. Umweltmedizin 5: 61–62
Knothe H (1982) Chemotherapie aktuell: Klebsiellen-wirksame Antibiotika. Umweltmedizin 5: 42
Knothe H (1982) Chemotherapie aktuell: Proteus-wirksame Antibiotika (Proteus mirabilis). Umweltmedizin 5: 82
Knothe H (1979) Wirkungsspektrum von Cefaclor. Diagn Intensivther 4: 1–8
Kobayashi GS, Medoff G (1983) Measurements of activity of antifungal drugs. In: Howard D (ed) Fungi pathogenic for humans and animals, Part B. Pathogenicity and Detection 1. Dekker, New York
Krasemann C (1981) Mikrobiologische Untersuchungen zu aktuellen Problemen der Chemotherapie. Thiemig, München
Kurzynski TA, Yrios JW, Helstad AG, Field CR (1976) Anaerobically incubated thioglycolate broth disc method for antibiotic susceptibility testing of anaerobes. Antimicrob Agents Chemother 10: 727–732
Ladey BW (1984) Antibiotic resistance in Staphylococcus aureus and streptococci. Br Med Bull 40: 77–83
Latham RH, Zeleznik D, Minshew BH, Schoenknecht FD, Stamm WE (1984) Staphylococcus saprophyticus β-lactamase production and disc diffusion susceptibility testing for three β-lactam antimicrobial agents. Antimicrob Agents Chemother 26: 670–672
Link D (1983) Untersuchungen zur Aktivität von Penicillinase-positiven und Penicilli- βnase-negativen Staphylococcus aureus-Stämmen gegenüber Penicillin-Antibiotika. Dissertation Universität Frankfurt, Frankfurt
Machka K, Balg H, Smith M, Braveny I (1978) Resistenzbestimmung von Haemophilus influenzae gegen Cotrimoxazol. Immun Infekt 6: 249–252
Machka K, Braveny I, Dabernet H, Dornbusch K, van Dyck E, Kayser FH, van Klingeren B, Mittermayer H, Perca E, Powell M (1988) Distribution and resistance patterns of Haemophilus influenzae: a European cooperative study. Eur Clin Microbiol Infect Dis 7: 14–24
Marre R (1983) Mechanismen der beta-Laktam-Resistenz von Escherichia coli und Proteus mirabilis. 39. Tagung der Deutschen Gesellschaft für Hygiene und Mikrobiologie, Bonn
McGinnis MR, Rinaldi MG (1986) Antifungal drugs: mechanisms of action, drug resistance, susceptibility testing, and assays of activity in biological fluids. In: Lorian V (ed) Antibiotics in Laboratory Medicine 2nd ed. Williams and Wilkins, Baltimore, London, Los Angeles, Sidney
Murray P, Granich GG, Krogstadt DJ, Niles AC (1983) In vivo selection of resistance to multiple cefalosporins by Enterobacter cloacae. J Infect Dis 147: 590
Murray PR, Zeitinger JR (1983) Evaluation of Mueller-Hinton-agar for disc diffusion susceptibility tests. J Clin Microbiol 18: 1269–1271
Neu HC (1982) Factors that affect the in-vitro activity of cephalosporin antibiotics. J Antimicrob Chemother 10: 11–23
Nikaido H (1984) Outer membrane permeability and β-lactam resistance. In: Leive L, Schlesinger D (eds) Microbiology 1984. American Society for Microbiology, Washington
Pruul H, McDonald PJ (1988) Damage to bacteria by antibiotics in vitro and its relevance to antimicrobial chemotherapy: a historical perspective. J Antimicrob Chemother 21: 695–700
Radetstky M, Wheeler RC, Roe MH, Todd JK (1986) Microtiter broth dilution method for yeast susceptibility testing with validation by clinical outcome. J Clin Microbiol 24: 600–606
Ringertz S, Kronvall G (1988) On the theory of the disk diffusion test. APMIS 96: 484–490
Rosen IG, Jacobsen J, Rudderman R (1972) Rapid capillary tube method for detecting penicillin resistance in Staphylococcus aureus. Appl Microbiol 23: 649
Rosenblatt JE (1985) Anaerobic bacteria in laboratory procedures in clinical microbiology. In: Washington JA (ed) Springer, Berlin Heidelberg New York Tokyo
Rosenblatt JE (1986) Antimicrobial susceptibility testing of anaerobes in antibiotics in laboratory medicine. In: Lorian V (ed) 2nd ed. Williams & Wilkins, Baltimore London Los Angeles Sidney
Ryan R, Tilton RC (1977) Rapid method for determining the minimum inhibitory concentration of ampicillin for Haemophilus influenzae. Antimicrob Agents Chemother 11: 114–117
Sahm DF, Baker CN, Jones RN, Thornsberry C (1983) Medium-dependent zone size discrepancies associated with susceptibility testing of group D-streptococci against various cephalosporins. J Clin Microbiol 18: 858–865
Seeliger HPR (1978) Pilze — Pilzerkrankungen (Mykosen). In: Otte HI, Brandis H (Hrsg) Lehrbuch der Medizinischen Mikrobiologie. 4. Aufl. Fischer, Stuttgart
Shah PM, Ottrad M, Stille W (1983) Antibakterielle Aktivität von Norfloxacin im Urin verglichen mit der von Cinoxacin, Nalidixinsäure und Pipemidsäure. Eur J Clin Microbiol 2: 273–275
Shanholtzer CJ, Peterson LR, Mohn ML, Moody JA, Gerding DN (1984) MBCs for Staphylococcus aureus as determined by macrodilution and microdilution techniques. Antimicrob Agents Chemother 26: 214–219
Smith JT (1984) Chemistry and mode of action of 4-quinolone agents. Fortschritte der antimikrobiellen und antineoplastischen Chemotherapie. Band 3–5, S 493–508
Sorgaard P (1984) β-Lactamase production in Enterobacter cloacae and Citrobacter freundii. Acta Pathol Microbiol Scand [B] 92:319–324
Svenson JM, Hill BC, Thornsberry C (1988) Authors reply. J Clin Microbiol 26: 611
Thabaut A, Meyran M (1984) La détermination de la concentration minima bactericide influence de différents facteurs techniques. Pathol Biol (Paris) 32: 351–354
Thornsberry C (1985) Automated procedures for antimicrobial susceptibility tests. In: Lennette EH, Balows A, Hausler WJ, Shadomy HJ (eds) Manual of Clinical Microbiology, 4th ed. American Society for Microbiology, Washington
Thornsberry C, Gavan TL, Sherris JC, Balows A, Matsen J, Sabath LD, Schoenknecht F, Thrupp LD, Washington JA (1975) Laboratory evaluation of a rapid automated susceptibility testing system: report of a collaborative study. Antimicrob Agents Chemother 7: 466–480
Tilton RC (1984) Antimicrobial susceptibility tests. In: Ristuccia AM, Cunha BA (eds) Antimicrobial Therapy. Raven Press, New York
Toala P, Schroeder SA, Daly AK, Finland M (1970) Candida at Boston City Hospital, clinical and epidemiological characteristics and susceptibility to eight antimicrobial agents. Arch Intern Med 126: 983–989
Tofte RW, Solliday J, Crossley KB (1984) Susceptibilities of enterococci to twelve antibiotics. Antimicrob Agents Chemother 25: 532–533
Ullmann U (1977) Correlation of minimum inhibitory concentration and beta-lactamase activity. Infection 5: 261–262
von Graevenitz A, Heitz M, Lüthy R, Meyer J, Vischer W (1984) Standardisierte Blättchentests zur Resistenzprüfung von Bakterien. Schweiz Med Wochenschr 144: 1079–1086
Washington JA, Snyder RJ, Kohner PC, Wioltsie CG, Ilstrup DM, McCall JT (1978) Effect of cation content of agar on the activity of gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa. J Infect Dis 137: 103
Washington JA, Sutter VL (1980) Dilution susceptibility test: agar and macro-broth dilution procedures. In: Lennette EH, Balows A, Hausler WJ, Truant JP (eds) Manual of Clinical Microbiology, 3rd ed. American Society for Microbiology, Washington
Werk R (1986) Neue Gesichtspunkte bei der bakteriologischen Diagnostik von Harnwegserkrankungen. In: Winz HR (Hrsg) Jahrbuch der Urologie 1986. Regensberg & Biermann, Münster
Werk R (1983) Untersuchungen zur Verwendbarkeit des Blättchenelutionstests in der Mykologie. 39. Tagung der Deutschen Gesellschaft für Hygiene und Mikrobiologie, Bonn
Werk R, Haaβ R (1982) Der Antimykotikablättchenelutionstest: eine neue quantitative Möglichkeit der Antimykotikatestung von Sproβpilzen. Immun Infekt 10: 110–114
Werk R, Knothe H (1984) Comparison of agar dilution test, broth dilution test, and broth elution test for assaying susceptibility of Candida spp. Curr Microbiol 10: 173–176
Wiedemann B (1983) Sensibilitätsbestimmung von Bakterien. Biotest-Serum-Institut GmbH, Frankfurt
Wilkins TD, Thiel T (1973) Modified broth-disk method for testing the antibiotic susceptibility of anaerobic bacteria. Antimicrob Agents Chemother 3: 350
Willgeroth F, Rummel W (1982) Medikamente in der Gravidität und Stillzeit. Fortschr Med 100: 1954–1958
Woolfrey BF, Fox JM, Quall CO (1981) A comparison of minimum inhibitory concentration values determined by three antimicrobic dilution methods for Pseudomonas aeruginosa. Am Soc Clin Pathol 75: 39–44
Woolfrey BF, Fox JM, Quail CO (1981) An analysis of error rates for disc agar-diffusion testing of Pseudomonas aeruginosa versus aminoglycosides. Am Soc Clin Pathol 75: 559–564
Woolfrey BF, Ramadei WA, Quall CO (1978) Inability of the standardized disc agar-diffusion test to measure susceptibility of the fluorescent group of Pseudomonas to gentamicin. Am J Clin Pathol 70: 337–342
Woolfrey BF, Ramadei WA, Quall CO (1979) Evaluation of the moving intermediate zone concept for determining susceptibility of Pseudomonas to gentamicin by the standardized disc agar-diffusion test. Am J Clin Pathol 72: 861–863
Yoshimura F, Nikaido H (1985) Diffusion of /Mactam antibiotics through the porin channels of Escherichia coli K-12k. Antimicrob Agents Chemother 27: 84–92
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Werk, R. (1990). In-vitro-Testung von Chemotherapeutika. In: Medizinische Bakteriologie und Infektiologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-75404-3_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-75404-3_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-52122-8
Online ISBN: 978-3-642-75404-3
eBook Packages: Springer Book Archive